Secreted immunomodulatory viral proteins as novel biotherapeutics
about
Viral and murine interleukin-10 are correctly processed and retain their biological activity when produced in tobacco.The α2,3-sialyltransferase encoded by myxoma virus is a virulence factor that contributes to immunosuppressionIdentification of myxomaviral serpin reactive site loop sequences that regulate innate immune responsesInhibition of chemokine-glycosaminoglycan interactions in donor tissue reduces mouse allograft vasculopathy and transplant rejectionRecombinant herpesvirus glycoprotein G improves the protective immune response to Helicobacter pylori vaccination in a mouse model of disease.Production of Myxoma virus gateway entry and expression libraries and validation of viral protein expressionThe agnoprotein of polyomavirus JC is released by infected cells: evidence for its cellular uptake by uninfected neighboring cells.Gene delivery of a viral anti-inflammatory protein to combat ocular inflammationProtein therapeutics--lessons learned and a view of the future.Expression of the E3L gene of vaccinia virus in transgenic mice decreases host resistance to vaccinia virus and Leishmania major infections.An ectromelia virus protein that interacts with chemokines through their glycosaminoglycan binding domain.Targeting leukocyte trafficking to inflamed skin: still an attractive therapeutic approach?Comparative proteomics of human monkeypox and vaccinia intracellular mature and extracellular enveloped virionsStrategies that modulate inflammasomes: insights from host-pathogen interactions.Myxoma virus and oncolytic virotherapy: a new biologic weapon in the war against cancer.Myxomavirus-derived serpin prolongs survival and reduces inflammation and hemorrhage in an unrelated lethal mouse viral infection.The immunoregulatory properties of oncolytic myxoma virus and their implications in therapeutics.Viral serpin therapeutics from concept to clinic.Structure-based release analysis of the JC virus agnoprotein regions: A role for the hydrophilic surface of the major alpha helix domain in release.Immunomodulating Drugs Based on Poxviral Proteins.Mechanisms of immunomodulation by mammalian and viral decoy receptors: insights from structures.Rodent herpesvirus Peru encodes a secreted chemokine decoy receptor.Immunoglobulin superfamily members encoded by viruses and their multiple roles in immune evasion.Myxoma virus: propagation, purification, quantification, and storageTicks produce highly selective chemokine binding proteins with antiinflammatory activity.Heparin alters viral serpin, serp-1, anti-thrombolytic activity to anti-thrombotic activity.The recombinant vaccinia virus gene product, B18R, neutralizes interferon alpha and alleviates histopathological complications in an HIV encephalitis mouse modelResonance assignments and secondary structure of vCCI, a 26 kDa CC chemokine inhibitor from rabbitpox virus.Myxoma viral serpin, Serp-1, inhibits human monocyte adhesion through regulation of actin-binding protein filamin B.Selective Deletion of Heparan Sulfotransferase Enzyme, Ndst1, in Donor Endothelial and Myeloid Precursor Cells Significantly Decreases Acute Allograft Rejection
P2860
Q21256644-ADBD39DC-AE13-4C97-968C-D1C9862DBDE2Q27312735-FBFA26A0-3434-4220-8E05-AEFA23A4FE6DQ28291150-10A54E9D-A21C-4374-9360-EBA39C25B2ADQ28752308-A5F72907-8FF8-42B7-9F2A-BD2D9722644EQ33560566-76292882-1750-411C-9026-F0F56E65C8D0Q33888269-729A4655-FCC3-4909-B32B-7232F5601460Q34434747-35B01186-F318-4BFE-B4F5-53B3C23B5ECEQ35000601-2D5604DD-D639-4F6B-9B55-E9718E5CFD0FQ36349537-0FD32D21-E0FC-4CFB-89B4-071187138862Q36423945-A755314C-FE19-4976-B0FE-BE1DE649FB77Q36424497-2E466FF9-A6AC-40CC-B834-62B2A7957D53Q36689220-5806F151-5322-465C-A45B-43E9ECD3DB3EQ36839627-7D6194FA-4C7D-49C9-A177-6C96A8E0B722Q36918695-430EBF4A-D30B-4019-A3E7-1308061B6695Q36922264-70F3700E-46B4-40A8-83D6-67297FB14556Q37124059-B70157B2-BAE5-4271-8300-18CA3CDD6A9DQ37787452-299554C3-F860-4698-8218-BA006520BF2AQ37891258-A7350DA6-FF47-46F9-898B-32681D9657BBQ38672601-943539A3-CC35-4BA6-AF05-1897249EC5DCQ38715016-267F4DD9-ECB1-478C-BE11-2726E47CD5B1Q39059671-56342699-8CB4-4890-B8ED-BF434B3815DFQ39068689-14684C3D-D27D-4294-B800-CE26BA3F595AQ39224323-88BED0E6-6FA2-4D6B-A8D5-DB8B6E8AFB88Q39707862-D15979E2-39E2-47E9-A7D2-7F4A6A463D9CQ40063162-2D69FABA-A692-480C-9FCC-D9082BC7445DQ42172490-446D5491-B389-4A7C-B50E-B9A582C43011Q42235552-726B9D3A-9BC6-4B85-8835-42714A5DA0E0Q45418928-BC44A4F4-0687-41C0-82E3-B387209384D4Q46217457-DAF08EC4-7B89-4759-AD19-BA5B9C0759CEQ58759632-AE7F44F4-7D5E-4B46-BDD3-D5379EDAF778
P2860
Secreted immunomodulatory viral proteins as novel biotherapeutics
description
2004 nî lūn-bûn
@nan
2004 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Secreted immunomodulatory viral proteins as novel biotherapeutics
@ast
Secreted immunomodulatory viral proteins as novel biotherapeutics
@en
Secreted immunomodulatory viral proteins as novel biotherapeutics
@nl
type
label
Secreted immunomodulatory viral proteins as novel biotherapeutics
@ast
Secreted immunomodulatory viral proteins as novel biotherapeutics
@en
Secreted immunomodulatory viral proteins as novel biotherapeutics
@nl
prefLabel
Secreted immunomodulatory viral proteins as novel biotherapeutics
@ast
Secreted immunomodulatory viral proteins as novel biotherapeutics
@en
Secreted immunomodulatory viral proteins as novel biotherapeutics
@nl
P1476
Secreted immunomodulatory viral proteins as novel biotherapeutics
@en
P2093
Alexandra Lucas
P304
P356
10.4049/JIMMUNOL.173.8.4765
P407
P577
2004-10-15T00:00:00Z